Personalised heart mapping for ventricular tachycardia treatment
Part of Heart & circulation clinical trials.
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 85 years old.
- You must be scheduled for a heart ablation procedure because of ventricular tachycardia.
- You must have an implantable cardioverter-defibrillator (ICD) already in place.
- You must have a heart condition called cardiomyopathy, which weakens the heart muscle.
- You must be able to give informed consent, and not have severe heart failure or other serious illnesses.
- If you can become pregnant, you must not be pregnant or breastfeeding during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This trial uses artificial intelligence to analyze heart images and guide doctors during a procedure to stop dangerous fast heart rhythms called ventricular tachycardia.
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
This study tests a new way of mapping damaged heart muscle to improve the precision of a procedure called catheter ablation, which treats dangerously fast heart rhythms. It may help people with heart disease who need this procedure.
This trial tests two different ways of mapping the heart to guide treatment for a dangerous fast heart rhythm. The goal is to see which mapping method works better for people with an ICD who need a procedure called ablation to stop the rhythm.
This trial tests a more detailed way to map the heart during an ablation procedure for ventricular tachycardia (a fast, abnormal heartbeat). It uses special catheters to find the exact spots causing the problem, which may help make the ablation safer and more effective.
Hear when a new Ventricular Tachycardia (VT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.